What happened with DSS today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
DSS, Inc.’s main business is Premier Packaging Corporation, which makes custom paperboard cartons, consumer-product packaging and security-printed documents, primarily for U.S. customers. Businesses in industries such as pharmaceuticals, consumer goods and food pay Premier to produce these materials. Packaging supplies most of DSS’s revenue, and one customer accounts for a substantial share of company-wide sales.
Its smaller financial businesses earn rent from medical properties held through AMRE and commissions from securities trading and underwriting, including through Sentinel Brokers. American Pacific Financial also provides business financing and third-party loan servicing, though lending contributes little revenue.
Biotechnology remains largely a development business. DSS funds research and develops intellectual property, seeking partners to license or jointly develop healthcare technologies. Its bio-health products are not yet commercially accepted; the division’s small current revenue comes from sales of the Celios air-purification brand.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Graphic Packaging competes with DSS’s Premier Packaging to sell paperboard cartons to food, beverage and consumer-product companies. Its Americas paperboard-packaging sales are worth watching for changes in demand from those shared customer groups.
Smurfit Westrock competes with DSS’s Premier Packaging for consumer-packaging customers, making its paperboard-packaging business the relevant part to watch. Smurfit Westrock makes both the board and the finished packaging; its consumer-packaging news matters more to this comparison than its corrugated-box business.
Impact BioMedical’s licensing success matters directly to DSS: approximately $17 million of DSS’s net intangible assets were tied to it at December 31, 2025, and unsuccessful licensing could lead to write-downs. Impact develops and patents healthcare and wellness technologies for partners to commercialize, so watch agreements that bring milestone or royalty payments from pharmaceutical, food or consumer-goods companies.
Alset, DSS’s largest shareholder and a holding company with real-estate, technology and biohealth businesses, links DSS’s funding to potential dilution through its August 2025 $500,000 loan. Alset can demand repayment or convert the loan into DSS shares at $0.86 each, and the first 12 months’ interest is payable in shares—making its repayment and conversion decisions worth watching.
Sonoco’s consumer-packaging sales offer a read on demand from food, beverage and other consumer-staples companies that also buy packaging from DSS’s Premier Packaging. Watch that business rather than Sonoco’s total sales, while allowing for its different mix of rigid packaging versus Premier’s folding cartons.
DSS, Inc. earningsThis company
DSS, Inc.’s packaging business brings in most of its revenue, and this report will show whether customer orders keep sales growing as the company cuts costs and cash burn.
Read packaging revenue alongside total costs and operating cash flow. Growing packaging revenue, lower costs and narrower operating cash outflow would show the core business contributing more while cost cuts take hold. Flat packaging revenue or persistently high costs and cash outflow would show that the revenue base is not yet closing the funding gap, leaving DSS reliant on financing or asset sales.
Fed Interest Rate Decision
The Fed’s interest-rate decision signals whether borrowing costs across the economy are rising or falling, affecting interest DSS pays on AMRE LifeCare’s variable-rate loan and its prime-rate note, and the cost of refinancing or raising new funds.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher rates can increase interest expense on AMRE LifeCare’s variable-rate loan and DSS’s prime-rate note, while making refinancing and new borrowing more costly for a company that needs financing.
If it comes in below expectations
Lower rates can ease interest costs on debt that reprices and reduce the cost of refinancing or new borrowing, giving DSS more room to meet its financing needs.
Graphic Packaging Holding Company earningsGPK
Graphic Packaging’s report will show how food, beverage and consumer-product companies are buying paperboard cartons, a read on demand among the customer groups it shares with DSS, Inc.’s Premier Packaging.
Watch Graphic Packaging’s Americas paperboard-packaging sales, not its total sales, alongside what it says about food, beverage and consumer-product demand. Stable or rising sales would suggest shared customers are sustaining packaging demand and the order backdrop for Premier Packaging is supportive; falling sales would point to weaker demand and tougher competition for orders.
